Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117093265 | 11709326 | 5 | F | 20160701 | 20151107 | 20160712 | EXP | ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-073574 | BRISTOL MYERS SQUIBB | 1.00 | DY | Y | 0.00000 | 20160712 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117093265 | 11709326 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Transplacental | UNK | U | 20972 | |||||||||
117093265 | 11709326 | 2 | SS | EMTRICITABINE W/RILPIVIRINE/TENOFOVIR DISOPRO | EMTRICITABINERILPIVIRINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
117093265 | 11709326 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Transplacental | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117093265 | 11709326 | 1 | Product used for unknown indication |
117093265 | 11709326 | 2 | Product used for unknown indication |
117093265 | 11709326 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117093265 | 11709326 | CA |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117093265 | 11709326 | Foetal exposure during pregnancy | |
117093265 | 11709326 | Polydactyly |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |